Benzinga | Nov 10, 2021 04:35PM EST

Marrone Bio Innovations Q3 EPS $(0.03), Inline, Sales $9.86M Miss $10.63M Estimate

Marrone Bio Innovations (NASDAQ:MBII) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 25 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $9.86 million which missed the analyst consensus estimate of $10.63 million by 7.28 percent. This is a 11.64 percent increase over sales of $8.83 million the same period last year.